Company news

Mayne Pharma Group Ltd. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Pause in Trading

November 20, 2025

Update on status of FIRB approval and second court hearing

November 20, 2025

MYX Declaration of Unacceptable Circumstances and Orders

November 19, 2025

Update on FIRB approval and Scheme

November 17, 2025

MYX - Panel Conducts Proceedings and Makes Interim Orders

November 14, 2025

Update on Scheme and Supreme Court of NSW proceedings

November 10, 2025

MYX Scheme of Arrangement update on FIRB approval

October 30, 2025

Outcome of litigation and update on Scheme

October 15, 2025

MYX announces PBS listing of NEXTSTELLIS in Australia

September 29, 2025

Mayne Pharma addresses recent media articles regarding FIRB

September 7, 2025

2025 Full Year Results Investor Presentation

August 28, 2025

2025 Full Year Results Media Release

August 28, 2025

Full Year Statutory Accounts

August 28, 2025

Sol-Gel Reports Second Quarter 2025 Financial Results and Provides Corporate Updates

August 15, 2025

Results of Scheme Meeting

June 18, 2025

Chair's address and presentation at the Scheme Meeting

June 17, 2025

Update on litigation with Cosette

June 15, 2025

Supplementary Scheme Booklet

June 4, 2025

Mayne Pharma receives purported notice to terminate SID

June 4, 2025

Update on Scheme of Arrangement with Cosette

June 3, 2025

Response to ASX Aware Letter

May 21, 2025

Update on Scheme with Cosette

May 20, 2025

ASIC registration of Mayne Pharma scheme booklet

May 15, 2025

Court approves convening of scheme meeting

May 15, 2025

Response to ASX Price Query

May 14, 2025

Pause in Trade

May 14, 2025

Response to ASX Query

May 11, 2025

Sol-Gel and Mayne Pharma Announce the Purchase of EPSOLAY® and TWYNEO® in the U.S.

April 17, 2025

2025 Half Year Investor Presentation

February 25, 2025

2025 Half Year Media Release

February 25, 2025

Mayne Pharma enters Scheme Implementation Deed with Cosette

February 20, 2025

Mayne Pharma market update

February 9, 2025

2024 AGM presentation and business update

November 20, 2024

Mayne Pharma reports FY24 financial results

August 23, 2024

2024 Full Year Results Investor Presentation

August 22, 2024

2024 Full Year Results Media Release

August 22, 2024

Appendix 4E and Full Year Statutory Accounts

August 22, 2024

Class action settlement

July 1, 2024

Notification of buy-back - MYX

May 23, 2024

Mayne Pharma reports 1H FY24 results with A 43% increase in revenue to A$188 million and $8 million underlying EBITDA

February 27, 2024

2024 Half Year Media Release

February 25, 2024

2024 Half Year Investor Presentation

February 25, 2024

Mayne Pharma to Present at the 42nd Annual J.P. Morgan Healthcare Conference

December 29, 2023

Issuance of additional US Patent for NEXTSTELLIS

November 5, 2023

Mayne Pharma provides update on first quarter 2024 trading and outlook

October 19, 2023

Mayne Pharma provides update on 1Q FY24 trading and outlook

October 17, 2023

2023 Full Year Results Investor Presentation

August 30, 2023

2023 Full Year Results Media Release

August 30, 2023

Preliminary Final Report

August 30, 2023

MYX provides investor update & announces on market buyback

May 9, 2023

← Newer news releases · Older news releases →

Calls

Decks

The 5 newest of 90 decks. Every deck is listed under its year.